<DOC>
	<DOCNO>NCT00422175</DOCNO>
	<brief_summary>The purpose study assess safety , tolerability , effect oral BAF312 bodily function well body 's absorption , distribution , metabolism , excretion BAF312 healthy volunteer</brief_summary>
	<brief_title>Single Dose Study Assess Safety , Tolerability , Concentration Body Effect BAF312</brief_title>
	<detailed_description />
	<criteria>Healthy male female subject , 18 55 year age include , good health Female subject must either surgically sterilize least 6 month prior study participation postmenopausal ( regular menstrual bleeding least 1 year ) Female subject test require negative result pregnancy test , lactating/breast feeding , must either : Body mass index ( BMI ) must within range 18 30 Kg/m2 . Subjects must weigh least 50 kg participate study . Able communicate investigator , understand comply requirement study Understand sign write informed consent firm Smokers Subjects receive live vaccine 4 week prior dose . Use prescription drug four week prior dose , overthecounter ( OTC ) medication ( vitamin , herbal supplement , dietary supplement ) within two week prior dose . Acetaminophen acceptable Participation clinical investigation within 4 week prior dose longer required local regulation , limitation participation base local regulation . Donation loss 400 ml blood within 8 week prior first dose , longer required local regulation . Significant illness within two week prior dose . A past personal close family medical history clinically significant cardiac abnormality History Acute chronic bronchospastic disease ( include asthma chronic obstructive pulmonary disease ) Clinically significant drug allergy history atopic allergy ( asthma , urticaria , eczematous dermatitis ) Known hypersensitivity severe adverse event darifenacin similar drug Any surgical medical condition might significantly alter absorption , distribution , metabolism excretion drug may jeopardize participation study Immunodeficiency disease , include positive HIV ( ELISA Western blot ) test result Positive Hepatitis B surface antigen ( HBsAg ) Hepatitis C test result . Drug alcohol abuse Additional protocol define inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>Safety , tolerability , pharmacokinetics , pharmacodynamics , oral , BAF312 , healthy volunteer</keyword>
</DOC>